Concepedia

Nina Wressnigg

NW

Statistics

Publications

18

Citations

1.1K

H-Index

17

Active since

2009

Affiliations

Valneva (Austria)(Current)

Medical University of Vienna

Vienna Biocenter

Baxter (Austria)

Research Institute of Influenza

Nina Wressnigg is an author at Valneva (Austria) specializing in infectious diseases, immunology, and vaccinology.

Publications per year

2009–2024

18

Publications

18

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 223 citations · Full text

, , +17

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl et al. · The Lancet Infectious Diseases · 2020 · 106 citations

, , +11

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger et al. · The Lancet Infectious Diseases · 2013 · 104 citations

, , +14

Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1

Brigitte M. Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko et al. · PLoS ONE · 2011 · 85 citations · Full text

, , +16

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial

Christopher Adlbrecht, Raphael Wurm, Pieter Depuydt et al. · Critical Care · 2020 · 80 citations · Full text

, , +14

1–5 of 18